Top Markets
Coin of the day
Myovant Sciences Ltd. Myovant Sciences Ltd.

Myovant Sciences Ltd.

MYOV
Peringkat dalam Saham #5525
Myovant Sciences Ltd. is a biopharmaceutical company focused on innovating... Myovant Sciences Ltd. is a biopharmaceutical company focused on innovating healthcare solutions for both women and men. Its flagship product is relugolix, an orally administered, once-daily small molecule that functions as a gonadotropin-releasing hormone (GnRH) receptor antagonist. This medication is indicated for conditions such as heavy menstrual bleeding caused by uterine fibroids, pain associated with endometriosis, and advanced prostate cancer. The company is also developing MVT-602, an oligopeptide kisspeptin agonist, currently in Phase II clinical trials for treating female infertility within assisted reproductive procedures. Myovant collaborates with Pfizer Inc. for the development and commercialization of relugolix across oncology and women's health sectors. Incorporated in 2016, initially as Roivant Endocrinology Ltd. before rebranding to Myovant Sciences Ltd. in May of that year, the firm is based in London, United Kingdom, and operates as a subsidiary of Sumitovant Biopharma Ltd.
Harga Saham
$26.98
Terakhir disinkronkan: 2023-03-09
Kapitalisasi Pasar
$2.62B
Perubahan (1 hari)
-0.04%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan Myovant Sciences Ltd. (MYOV)

Kategori

Riwayat harga saham Myovant Sciences Ltd. (MYOV)
Harga penutupan tertinggi: $26.97 pada 2023-03-01

Harga penutupan terendah: $12.79 pada 2016-10-01
Riwayat harga saham Myovant Sciences Ltd. dari 2016 hingga 2026
Performa harga saham tahunan
Tahun Performa
2023 0.28%
2022 73.07%
2021 -37.07%
2020 50.47%
2019 -4.83%
2018 41.15%
2017 8.58%
2016 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$549.38 41.20%
US
$1.05K 47.75%
NL
$148.35 491.02%
US
$122.63 -12.65%
AU
$763.69 6.97%
CH